HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China
· Delayed Price · Currency is CNY 10.49
+0.11 (1.06%)
Mar 10, 2026, 3:00 PM CST
SHA:600829 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,083 | 4,349 | 4,535 | 3,700 | 3,897 | 4,303 | Upgrade
|
| Market Cap Growth | 36.23% | -4.09% | 22.57% | -5.06% | -9.43% | 8.80% | Upgrade
|
| Enterprise Value | 6,197 | 4,499 | 4,654 | 3,912 | 4,575 | 4,515 | Upgrade
|
| Last Close Price | 10.49 | 7.50 | 7.62 | 6.22 | 6.55 | 7.09 | Upgrade
|
| PE Ratio | 51.05 | 20.39 | 15.52 | 13.99 | 14.05 | 29.62 | Upgrade
|
| PS Ratio | 0.60 | 0.43 | 0.44 | 0.38 | 0.42 | 0.54 | Upgrade
|
| PB Ratio | 2.03 | 1.51 | 1.65 | 1.51 | 1.77 | 2.16 | Upgrade
|
| P/TBV Ratio | 2.05 | 1.52 | 1.66 | 1.52 | 1.80 | 2.19 | Upgrade
|
| P/FCF Ratio | 189.21 | 40.50 | 14.65 | 12.30 | - | - | Upgrade
|
| P/OCF Ratio | 135.80 | 37.68 | 13.62 | 12.04 | - | - | Upgrade
|
| EV/Sales Ratio | 0.61 | 0.45 | 0.45 | 0.41 | 0.49 | 0.56 | Upgrade
|
| EV/EBITDA Ratio | 24.15 | 14.10 | 10.78 | 9.69 | 10.48 | 16.26 | Upgrade
|
| EV/EBIT Ratio | 31.46 | 15.00 | 11.31 | 10.21 | 11.08 | 17.86 | Upgrade
|
| EV/FCF Ratio | 192.74 | 41.89 | 15.04 | 13.00 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.25 | 0.31 | 0.37 | 0.52 | 0.60 | 0.31 | Upgrade
|
| Debt / EBITDA Ratio | 2.86 | 2.50 | 2.16 | 2.84 | 2.80 | 2.20 | Upgrade
|
| Debt / FCF Ratio | 22.83 | 8.38 | 3.29 | 4.22 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.04 | -0.07 | -0.11 | 0.04 | 0.24 | 0.10 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.53 | -0.63 | -0.68 | 0.22 | 1.21 | 0.69 | Upgrade
|
| Net Debt / FCF Ratio | 3.53 | -1.86 | -0.95 | 0.29 | -2.15 | -8.28 | Upgrade
|
| Asset Turnover | 1.45 | 1.38 | 1.44 | 1.40 | 1.46 | 1.39 | Upgrade
|
| Inventory Turnover | 8.63 | 8.29 | 8.59 | 8.02 | 7.48 | 6.26 | Upgrade
|
| Quick Ratio | 1.37 | 1.33 | 1.27 | 1.22 | 1.15 | 1.11 | Upgrade
|
| Current Ratio | 1.68 | 1.62 | 1.53 | 1.48 | 1.42 | 1.43 | Upgrade
|
| Return on Equity (ROE) | 4.06% | 7.57% | 11.22% | 11.36% | 13.19% | 7.55% | Upgrade
|
| Return on Assets (ROA) | 1.75% | 2.57% | 3.55% | 3.47% | 4.05% | 2.74% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.63% | 8.62% | 12.23% | 11.12% | 12.97% | 7.96% | Upgrade
|
| Return on Capital Employed (ROCE) | 6.30% | 9.90% | 14.20% | 14.60% | 17.30% | 11.90% | Upgrade
|
| Earnings Yield | 1.96% | 4.90% | 6.44% | 7.15% | 7.12% | 3.38% | Upgrade
|
| FCF Yield | 0.53% | 2.47% | 6.83% | 8.13% | -6.29% | -0.54% | Upgrade
|
| Dividend Yield | - | - | 1.89% | - | - | 1.69% | Upgrade
|
| Payout Ratio | 21.47% | 75.22% | 8.43% | 11.53% | 12.86% | 2.93% | Upgrade
|
| Buyback Yield / Dilution | 0.02% | 0.01% | -0.01% | 0.00% | 0.20% | -0.20% | Upgrade
|
| Total Shareholder Return | 0.02% | 0.01% | 1.88% | 0.00% | 0.20% | 1.49% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.